<?xml version="1.0" encoding="UTF-8"?>
<p>The secondary outcomes were the improvement rate in the PDS, EPS, Gastrointestinal Symptom Rating Scale (GSRS), and quality of life scores at the end and two weeks after the intervention. Also, safety and tolerability were assessed.</p>
